Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Polio-Haemophilus Influenzae Type b Adsorbed (DTaP-HB-IPV-Hib)

• Infanrix hexa® 
  

Diphtheria-Tetanus-Acellular Pertussis-Polio-Haemophilus Influenzae Type b Adsorbed (DTaP-IPV-Hib)‎

• Infanrix®-IPV/Hib and Pediacel®
  

Tetanus-Diphtheria-Acellular Pertussis Adsorbed-Inactivated Polio (Tdap-IPV)

• Adacel®-Polio and Boostrix®-Polio
  

Tetanus-Diphtheria-Acellular Pertussis (Tdap)

• Adacel® and Boostrix®
  

Tetanus-Diphtheria Adsorbed (Td)

• Td Adsorbed
  

Tetanus Prophylaxis in Wound Management

Haemophilus b Conjugate Vaccine

• Act-HIB® and Hiberix‎® 
  

For combination vaccines see Diphtheria and Tetanus-containing Vaccines

Hepatitis A Vaccine (Inactivated Viral) 

• Hepatitis A Vaccine Indications
  
• Avaxim® and Avaxim® Pediatric
  
• Havrix® 1440 and Havrix® 720 Junior
  
• Vaqta®
  

Hepatitis B Vaccine (Inactivated Viral)

• Hepatitis B Vaccine Pre-Exposure Indications
  
• Hepatitis B Vaccine for Students of Health Care Professions
  
• Hepatitis B Vaccine Post-Exposure Indications
  
• Hepatitis B Post-Exposure Prophylaxis
  
• Engerix®-B
  
• Recombivax HB®
  
• Hepatitis B Vaccine Higher Dose Schedule
  
• Hepatitis B Vaccine Program for Chronic Kidney Disease Clients
  

Hepatitis A and B Vaccine Combined (Inactivated Viral)

• Twinrix® and Twinrix® Junior‎
  

Human Papillomavirus Vaccine (Nonavalent)

• Gardasil®9
  

Human Papillomavirus Vaccine (Bivalent)

• Cervarix‎®
  

Hepatitis B Immune Globulin (HBIg)

• HepaGam B® and HyperHEP B® S/D
  

Immune Globulin (Ig)

• GamaSTAN®
  

Rabies Immune Globulin (RabIg)

• HyperRAB® 
• Imogam® Rabies Pasteurized
  
• KamRAB™
  

Tetanus Immune Globulin (TIg)

• HyperTET® S/D
  

Varicella Zoster Immune Globulin (VarIg)

• Vari‎ZIG® 
  

Immune Globulin Preparations (HBIg, Ig, TIg, VarIg, RabIg)

Immune Globulin Preparations or Blood: Timing Intervals for Vaccines Containing Live Measles, Mumps, Rubella or Varicella Virus

2021/22 Seasonal Influenza Vaccine Eligibility: Quadrivalent Inactivated Influenza Vaccines (QIIV) and Quadrivalent Live Attenuated Influenza Vaccine (LAIV-Q)

Safety Issues Applicable to Influenza Vaccines

Intended Use of Influenza Vaccines

Quadrivalent Live Attenuated Influenza Vaccine (LAIV-Q)

• Flumist® Quadrivalent
  

Quadrivalent Inactivated Influenza Vaccine (Inactivated Split Virion) (QIIV)

• Afluria® Tetra
  
• FluLaval® Tetra
  
• Fluzone® Quadrivalent

Meningococcal B Vaccine (four component recombinant, adsorbed)

• Bexsero®
  

Meningococcal C Conjugate (MCC) Vaccine

• NeisVac-C® and Menjugate®
  

Meningococcal Quadrivalent Conjugate Vaccines (Groups A, C, Y, W-135)

• Menveo®, Menactra® and Nimenrix‎®
  

Measles-Mumps-Rubella Vaccine (Live Attenuated Viral)

• MMR® II and Priorix®
  

Combination Measles-Mumps-Rubella and Varicella Vaccine (MMRV)

• Priorix-Tetra® and Proquad®‎
  

Pneumococcal Conjugate Vaccine

• Prevnar® 13
  
• Completing a Pneumococcal Conjugate Vaccine Series
  

Pneumococcal Polysaccharide Vaccine

• Pneumovax® 23‎
  

Polio Vaccine (Inactivated)

• Imovax® Polio‎
  

For combination vaccines see Diphtheria and Tetanus-containing Vaccines

Post-Exposure Prophylaxis

• Imovax® Rabies and RabAvert®
  

Pre-Exposure Prophylaxis

• Imovax® Rabies and RabAvert‎®
  

Rotavirus Vaccine (Human rotavirus, live attenuated, oral vaccine)

• Rotarix®
  
• RotaTeq‎®
  

Varicella Vaccine (Live Attenuated Viral Vaccine)

• Varilrix® and Varivax® III‎
  

Zoster Vaccine (Recombinant)

• Shingrix®
  

Zoster Vaccine (Live Attenuated Viral Vaccine)

• Zostavax® II‎